catalog number :
MBS2004075
products full name :
Polyclonal Antibody to Decay Accelerating Factor (DAF)
products short name :
[Decay Accelerating Factor (DAF)]
other names :
[complement decay-accelerating factor, GPI-anchored preproprotein; Complement decay-accelerating factor, GPI-anchored; complement decay-accelerating factor, GPI-anchored; CD55 molecule, decay accelerating factor for complement; CD_antigen: CD55]
products gene name :
[DAF]
other gene names :
[Cd55; Cd55; Daf; Daf1; Daf-GPI; GPI-DAF; Cd55a; Daf; Daf1; DAF-GPI]
reactivity :
Mus musculus (Mouse)
sequence :
Antigen: The target protein is fused with N-terminal His-Tag and its sequence is listed below. MGHHHHHHSGSEF- PILG RHSKFAEQSK VAYSCNNGFK QVPDKSNIVV CLENGQWSSH ETFCEKSCVA PERLSFASLK KEYLNMNFFP VGTIVEYECR PGFRKQPPLP GKATCLEDLV WSPVAQFCKK KSCPNPKDLD NGHINIPTGI LFGSEINFSC NPGYRLVGVS STFCSVTGNT VDWDDEFPVC TEIHCPEPPK INNGIMRGES DSYTYSQVVT YSCDKGFILV GNASIYCTVS KSDVGQWSSP PPRCIE
specificity :
The antibody is a rabbit polyclonal antibody raised against DAF. It has been selected for its ability to recognize DAF in immunohistochemical staining and western blotting.
purity :
Antigen-specific Affinity Chromatography.
form :
Supplied as solution form in PBS, pH7.4, containing 0.02% NaN3,50% glycerol.
storage stability :
Storage: Avoid repeated freeze/thaw cycles. Store at 4oC for frequent use. Aliquot and store at -20oC for 12 months. Stability Test: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37oC for 48h, and no obvious degradation and precipitation were observed.The loss rate is less than 5% within the expiration date under appropriate storage condition.
tested application :
WB; ICC; IHC-P; IHC-F; ELISA; IP; IF; FCM.
app notes :
Western blotting: 0.5-2ug/ml. Immunocytochemistry in formalin fixed cells: 5-20ug/ml. Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml. Immunohistochemistry in paraffin section: 5-20ug/ml. Enzyme-linked Immunosorbent Assay: 0.05-2ug/ml. Optimal working dilutions must be determined by end user.
image1 heading :
Western Blot (WB)
image2 heading :
Western Blot (WB)
image3 heading :
Immunohistochemistry (IHC)
image4 heading :
Immunohistochemistry (IHC)
image4 description :
DAB staining on IHC-P; Samples: Mouse Stomach Tissue
image5 heading :
Immunohistochemistry (IHC)
image5 description :
DAB staining on IHC-P; Samples: Mouse Spleen Tissue
other info1 :
Source: Polyclonal antibody preparation. Traits: Liquid
other info2 :
Immunogen: Recombinant DAF (Pro47~Glu286) expressed in E.coli. Conjugated Antibody: The APC conjugated antibody version of this item is also available as catalog #MBS2042690
ncbi acc num :
NP_034146.2
ncbi gb acc num :
NM_010016.3
ncbi mol weight :
42,618 Da
ncbi pathways :
Allograft Rejection Pathway (920963); Asparagine N-linked Glycosylation Pathway (1367240); COPI-mediated Anterograde Transport Pathway (1367178); Class B/2 (Secretin Family Receptors) Pathway (1367080); Complement Activation, Classical Pathway (198379); Complement And Coagulation Cascades Pathway (198335); Complement And Coagulation Cascades Pathway (83270); Complement And Coagulation Cascades Pathway (484); Complement Cascade Pathway (1367536); ER To Golgi Anterograde Transport Pathway (1367175)
ncbi summary :
This gene encodes an inhibitor of both the classical and the alternative pathways of complement activation. The encoded preproprotein undergoes post-translational processing to generate a mature polypeptide anchored to the plasma membrane via a glycosylphosphatidylinositol moiety. Erythrocytes from mice deficient in the encoded protein exhibit impaired regulation of complement activation resulting in enhanced complement deposition. Mice lacking the encoded protein exhibit enhanced susceptibility to experimentally induced myasthenia gravis. This gene is located adjacent to a closely related gene on chromosome 1. [provided by RefSeq, Nov 2015]
uniprot summary :
CD55: This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade. Belongs to the receptors of complement activation (RCA) family. 2 isoforms of the human protein are produced by alternative splicing. Protein type: Cell surface; Membrane protein, GPI anchor. Chromosomal Location of Human Ortholog: 1 E4 1 56.89 cM. Cellular Component: apical plasma membrane; cell surface; external side of plasma membrane; membrane; membrane raft; plasma membrane. Molecular Function: enzyme inhibitor activity; lipid binding; viral receptor activity. Biological Process: complement activation, classical pathway; immune system process; innate immune response; regulation of complement activation, classical pathway